Bleeding risks of antithrombotic therapy.
Fitzmaurice
David A
DA
Blann
Andrew D
AD
Lip
Gregory Y H
GY
D000925:Anticoagulants / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects; D012307:Risk Factors; D013927:Thrombosis / Q000188:drug therapy*; D014859:Warfarin / Q000009:adverse effects
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D001241:Aspirin